Cancer Research Audrey Hepburn Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bao, S.
Right arrow Articles by Rich, J. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bao, S.
Right arrow Articles by Rich, J. N.
[Cancer Research 66, 7843-7848, August 15, 2006]
© 2006 American Association for Cancer Research

Priority Reports

Stem Cell–like Glioma Cells Promote Tumor Angiogenesis through Vascular Endothelial Growth Factor

Shideng Bao1,5, Qiulian Wu1,5, Sith Sathornsumetee1,5, Yueling Hao1,5, Zhizhong Li6, Anita B. Hjelmeland1,5, Qing Shi1,5, Roger E. McLendon2, Darell D. Bigner1,2,5 and Jeremy N. Rich1,3,4,5,6

Departments of 1 Surgery, 2 Pathology, 3 Medicine, and 4 Neurobiology; 5 Preston Robert Tisch Brain Tumor Center; and 6 Molecular Cancer Biology Program, Duke University Medical Center, Durham, North Carolina

Requests for reprints: Jeremy N. Rich, Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Box 2900, Durham, NC 27710. Phone: 919-681-1693; Fax: 919-684-6514; E-mail: rich0001{at}mc.duke.edu.

Malignant gliomas are highly lethal cancers dependent on angiogenesis. Critical tumor subpopulations within gliomas share characteristics with neural stem cells. We examined the potential of stem cell–like glioma cells (SCLGC) to support tumor angiogenesis. SCLGC isolated from human glioblastoma biopsy specimens and xenografts potently generated tumors when implanted into the brains of immunocompromised mice, whereas non-SCLGC tumor cells isolated from only a few tumors formed secondary tumors when xenotransplanted. Tumors derived from SCLGC were morphologically distinguishable from non-SCLGC tumor populations by widespread tumor angiogenesis, necrosis, and hemorrhage. To determine a potential molecular mechanism for SCLGC in angiogenesis, we measured the expression of a panel of angiogenic factors secreted by SCLGC. In comparison with matched non-SCLGC populations, SCLGC consistently secreted markedly elevated levels of vascular endothelial growth factor (VEGF), which were further induced by hypoxia. In an in vitro model of angiogenesis, SCLGC-conditioned medium significantly increased endothelial cell migration and tube formation compared with non-SCLGC tumor cell–conditioned medium. The proangiogenic effects of glioma SCLGC on endothelial cells were specifically abolished by the anti-VEGF neutralizing antibody bevacizumab, which is in clinical use for cancer therapy. Furthermore, bevacizumab displayed potent antiangiogenic efficacy in vivo and suppressed growth of xenografts derived from SCLGC but limited efficacy against xenografts derived from a matched non-SCLGC population. Together these data indicate that stem cell–like tumor cells can be a crucial source of key angiogenic factors in cancers and that targeting proangiogenic factors from stem cell–like tumor populations may be critical for patient therapy. (Cancer Res 2006; 66(16): 7843-8)




This article has been cited by other articles:


Home page
 Neuro OncologyHome page
H. Colman, L. Zhang, E. P. Sulman, J. M. McDonald, N. L. Shooshtari, A. Rivera, S. Popoff, C. L. Nutt, D. N. Louis, J. G. Cairncross, et al.
A multigene predictor of outcome in glioblastoma
Neuro Oncology, October 20, 2009; (2009) nop007v1.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. Pietras, L. M. Hansford, A. S. Johnsson, E. Bridges, J. Sjolund, D. Gisselsson, M. Rehn, S. Beckman, R. Noguera, S. Navarro, et al.
HIF-2{alpha} maintains an undifferentiated state in neural crest-like human neuroblastoma tumor-initiating cells
PNAS, September 29, 2009; 106(39): 16805 - 16810.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Folkins, Y. Shaked, S. Man, T. Tang, C. R. Lee, Z. Zhu, R. M. Hoffman, and R. S. Kerbel
Glioma Tumor Stem-Like Cells Promote Tumor Angiogenesis and Vasculogenesis via Vascular Endothelial Growth Factor and Stromal-Derived Factor 1
Cancer Res., September 15, 2009; 69(18): 7243 - 7251.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. H. Schilling, A. B. Hjelmeland, D. R. Radiloff, I. M. Liu, T. P. Wakeman, J. R. Fielhauer, E. H. Foster, J. D. Lathia, J. N. Rich, X.-F. Wang, et al.
NDRG4 Is Required for Cell Cycle Progression and Survival in Glioblastoma Cells
J. Biol. Chem., September 11, 2009; 284(37): 25160 - 25169.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
G. Frosina
DNA Repair and Resistance of Gliomas to Chemotherapy and Radiotherapy
Mol. Cancer Res., July 1, 2009; 7(7): 989 - 999.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Z. Li, H. Wang, C. E. Eyler, A. B. Hjelmeland, and J. N. Rich
Turning Cancer Stem Cells Inside Out: An Exploration of Glioma Stem Cell Signaling Pathways
J. Biol. Chem., June 19, 2009; 284(25): 16705 - 16709.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
A. S. Chi, A. G. Sorensen, R. K. Jain, and T. T. Batchelor
Angiogenesis as a Therapeutic Target in Malignant Gliomas
Oncologist, June 1, 2009; 14(6): 621 - 636.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
M. W. Graner, O. Alzate, A. M. Dechkovskaia, J. D. Keene, J. H. Sampson, D. A. Mitchell, and D. D. Bigner
Proteomic and immunologic analyses of brain tumor exosomes
FASEB J, May 1, 2009; 23(5): 1541 - 1557.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
A. M. McCord, M. Jamal, U. T. Shankavarum, F. F. Lang, K. Camphausen, and P. J. Tofilon
Physiologic Oxygen Concentration Enhances the Stem-Like Properties of CD133+ Human Glioblastoma Cells In vitro
Mol. Cancer Res., April 1, 2009; 7(4): 489 - 497.
[Abstract] [Full Text] [PDF]

Home page
 Cold Spring Harb Symp Quant BiolHome page
J.N. Rich and C.E. Eyler
Cancer Stem Cells in Brain Tumor Biology
Cold Spring Harb Symp Quant Biol, March 27, 2009; (2009) sqb.2008.73.060v1.
[Abstract] [PDF]

Home page
 Vet PatholHome page
J. E. Trosko
REVIEW PAPER: Cancer Stem Cells and Cancer Nonstem Cells: From Adult Stem Cells or from Reprogramming of Differentiated Somatic Cells
Vet. Pathol., March 1, 2009; 46(2): 176 - 193.
[Abstract] [Full Text] [PDF]

Home page
 Neuro Oncol DukeHome page
K. Jahnke, L. L. Muldoon, C. G. Varallyay, S. J. Lewin, D. F. Kraemer, and E. A. Neuwelt
Bevacizumab and carboplatin increase survival and asymptomatic tumor volume in a glioma model
Neuro-oncol, January 1, 2009; 11(2): 142 - 150.
[Abstract] [Full Text] [PDF]

Home page
 Am Soc Clin Oncol Ed BookHome page
P. Y. Wen, A. D. Norden, and J. Drappatz
Antiangiogenic Therapies for Malignant Gliomas
ASCO Educational Book, January 1, 2009; 2009(1): 113 - 117.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. C. Milsom, J. L. Yu, N. Mackman, J. Micallef, G. M. Anderson, A. Guha, and J. W. Rak
Tissue Factor Regulation by Epidermal Growth Factor Receptor and Epithelial-to-Mesenchymal Transitions: Effect on Tumor Initiation and Angiogenesis
Cancer Res., December 15, 2008; 68(24): 10068 - 10076.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
S. Ledoux, I. Queguiner, S. Msika, S. Calderari, P. Rufat, J.-M. Gasc, P. Corvol, and E. Larger
Angiogenesis Associated With Visceral and Subcutaneous Adipose Tissue in Severe Human Obesity
Diabetes, December 1, 2008; 57(12): 3247 - 3257.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Desjardins, D. A. Reardon, J. E. Herndon II, J. Marcello, J. A. Quinn, J. N. Rich, S. Sathornsumetee, S. Gururangan, J. Sampson, L. Bailey, et al.
Bevacizumab Plus Irinotecan in Recurrent WHO Grade 3 Malignant Gliomas
Clin. Cancer Res., November 1, 2008; 14(21): 7068 - 7073.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
I. L. Weissman and J. A. Shizuru
The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases
Blood, November 1, 2008; 112(9): 3543 - 3553.
[Abstract] [Full Text] [PDF]

Home page
 J Child NeurolHome page
B. A. Emmenegger and R. J. Wechsler-Reya
Stem Cells and the Origin and Propagation of Brain Tumors
J Child Neurol, October 1, 2008; 23(10): 1172 - 1178.
[Abstract] [PDF]

Home page
 The OncologistHome page
A. Idbaih, F. Ducray, M. Sierra Del Rio, K. Hoang-Xuan, and J.-Y. Delattre
Therapeutic Application of Noncytotoxic Molecular Targeted Therapy in Gliomas: Growth Factor Receptors and Angiogenesis Inhibitors
Oncologist, September 1, 2008; 13(9): 978 - 992.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Bao, Q. Wu, Z. Li, S. Sathornsumetee, H. Wang, R. E. McLendon, A. B. Hjelmeland, and J. N. Rich
Targeting Cancer Stem Cells through L1CAM Suppresses Glioma Growth
Cancer Res., August 1, 2008; 68(15): 6043 - 6048.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
P. Y. Wen and S. Kesari
Malignant Gliomas in Adults
N. Engl. J. Med., July 31, 2008; 359(5): 492 - 507.
[Full Text] [PDF]

Home page
 JCOHome page
C. E. Eyler and J. N. Rich
Survival of the Fittest: Cancer Stem Cells in Therapeutic Resistance and Angiogenesis
J. Clin. Oncol., June 10, 2008; 26(17): 2839 - 2845.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
P. B. Dirks
Brain Tumor Stem Cells: Bringing Order to the Chaos of Brain Cancer
J. Clin. Oncol., June 10, 2008; 26(17): 2916 - 2924.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
R. S. Kerbel
Tumor Angiogenesis
N. Engl. J. Med., May 8, 2008; 358(19): 2039 - 2049.
[Full Text] [PDF]

Home page
 Genes Dev.Home page
F. B. Furnari, T. Fenton, R. M. Bachoo, A. Mukasa, J. M. Stommel, A. Stegh, W. C. Hahn, K. L. Ligon, D. N. Louis, C. Brennan, et al.
Malignant astrocytic glioma: genetics, biology, and paths to treatment
Genes & Dev., November 1, 2007; 21(21): 2683 - 2710.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
W. Chen, S. Delaloye, D. H.S. Silverman, C. Geist, J. Czernin, J. Sayre, N. Satyamurthy, W. Pope, A. Lai, M. E. Phelps, et al.
Predicting Treatment Response of Malignant Gliomas to Bevacizumab and Irinotecan by Imaging Proliferation With [18F] Fluorothymidine Positron Emission Tomography: A Pilot Study
J. Clin. Oncol., October 20, 2007; 25(30): 4714 - 4721.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. J. Vredenburgh, A. Desjardins, J. E. Herndon II, J. Marcello, D. A. Reardon, J. A. Quinn, J. N. Rich, S. Sathornsumetee, S. Gururangan, J. Sampson, et al.
Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme
J. Clin. Oncol., October 20, 2007; 25(30): 4722 - 4729.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. N. Rich
Cancer Stem Cells in Radiation Resistance
Cancer Res., October 1, 2007; 67(19): 8980 - 8984.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
S. Senan and E. F. Smit
Design of Clinical Trials of Radiation Combined with Antiangiogenic Therapy
Oncologist, April 1, 2007; 12(4): 465 - 477.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. J. Vredenburgh, A. Desjardins, J. E. Herndon II, J. M. Dowell, D. A. Reardon, J. A. Quinn, J. N. Rich, S. Sathornsumetee, S. Gururangan, M. Wagner, et al.
Phase II Trial of Bevacizumab and Irinotecan in Recurrent Malignant Glioma
Clin. Cancer Res., February 15, 2007; 13(4): 1253 - 1259.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.